Outcomes following neuromuscular blockade in patients receiving tracheostomies.

Autor: Bauer E; The Ohio State University College of Medicine, Columbus, OH, United States., Mahida JB; Center for Surgical Outcomes Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Division of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, United States., Boomer LA; Division of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, United States., Lutmer JE; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States; Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, OH, United States., Minneci PC; Center for Surgical Outcomes Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Division of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, United States., Deans KJ; Center for Surgical Outcomes Research, The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Division of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, United States., Elmaraghy CA; Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, United States; Department of Pediatric Otolaryngology, Nationwide Children's Hospital, Columbus, OH, United States. Electronic address: charles.elmaraghy@nationwidechildrens.org.
Jazyk: angličtina
Zdroj: International journal of pediatric otorhinolaryngology [Int J Pediatr Otorhinolaryngol] 2016 May; Vol. 84, pp. 101-5. Date of Electronic Publication: 2016 Mar 04.
DOI: 10.1016/j.ijporl.2016.02.027
Abstrakt: Objective: The purpose of this study is to determine whether the use of neuromuscular blockade agents (NMBAs) in pediatric patients following tracheostomy is associated with increased rates of complications or a prolonged length of stay.
Methods: This was a single-center retrospective chart review of pediatric patients undergoing tracheostomy placement between 2010 and 2013 who were admitted to the pediatric or neonatal intensive care units and did or did not receive NMBA within 7 days post-procedure.
Results: Out of 114 included patients, 26 (23%) received NMBAs during the postoperative period. Patients receiving NMBAs were more likely to have cardiac disease and preoperative respiratory failure but less likely to have neurologic disease. Patients receiving NMBAs had a longer median postoperative length of stay (33 vs. 23 days, p=0.043) and were more likely to have postoperative ileus (12% vs. 3%, p=0.037).
Conclusion: In patients undergoing tracheostomy placement, use of NMBAs is associated with prolonged postoperative hospital courses. NMBAs are not associated with a higher likelihood of postoperative complications.
(Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: